Dr. Dhananjay Kumar Tiwary gets additional charge as Managing Director of BIRAC

Veteran health innovation and policy leader to drive biotechnology innovation, startup growth and commercialization of indigenous technologies

Cipla Health elevates Kunal Mehta to Associate Director – Marketing

Marketing leader behind growth of brands such as Cipladine, Maxirich, and Soak Shield takes on expanded responsibilities to drive portfolio growth and consumer engagement.

Dr. Alka Rao becomes first woman director of CSIR-IMTECH

Accomplished molecular microbiologist and protein engineer takes charge of CSIR-IMTECH after serving in key scientific and regulatory leadership roles at FSSAI

Punita Kumar-Sinha appointed Independent Director at Aurobindo Pharma USA

Seasoned governance expert and board leader brings extensive experience in strategic oversight, risk management, and corporate governance across multiple sectors

Cipla appoints Taher Karampurwala as Senior Director and Head of Middle East Business

Veteran pharmaceutical executive to relocate to Saudi Arabia and spearhead Cipla’s growth strategy across the Middle East region

Aragen Life Sciences elevates Pavan Kumar Kamarajugadda to Senior Director

Amgen appoints Madhur Sarin as Director – AI & Data Science COE

Sarin will focus on advancing scalable AI-driven platforms and strengthening the company’s global data science capabilities across healthcare and enterprise technology domains

Expanding our technical portfolio with advanced ICP-OES Series to boost India's analytical capabilities: Santosh Kumar, Managing Director, Analytik Jena India

We are contributing to the Indian pharmaceutical and laboratory sectors through advanced analytical instrumentation, automated liquid handling, and molecular biology solutions. Our technologies empower research and Quality Control (QC) by ensuring regulatory compliance and streamlined workflows…

Empowering life sciences and diagnostics with balanced, scalable technologies: Dev Ananthan, Director of Strategic Marketing, Danaher Lifesciences

Our Global Capability Center (GCC) in Bengaluru drives our major software development initiatives. Complementing this, our Bengaluru facility manufactures antibodies for research and diagnostics. Through these integrated technology and biotech operations, we are proud to contribute to India’s growth story in the life sciences sector.

With 14 acquisitions under our belt in last 5 years, we are ready for more: Pradeep Nair, Managing Director - India, Cole-Parmer

We are also acquiring company into lab equipment. We have product that meets the requirement of laboratory equipment from end to end.